Thio- and oxoflavopiridols, cyclin-dependent kinase 1-selective inhibitors: Synthesis and biological effects

Citation
Ks. Kim et al., Thio- and oxoflavopiridols, cyclin-dependent kinase 1-selective inhibitors: Synthesis and biological effects, J MED CHEM, 43(22), 2000, pp. 4126-4134
Citations number
41
Categorie Soggetti
Chemistry & Analysis
Journal title
JOURNAL OF MEDICINAL CHEMISTRY
ISSN journal
00222623 → ACNP
Volume
43
Issue
22
Year of publication
2000
Pages
4126 - 4134
Database
ISI
SICI code
0022-2623(20001102)43:22<4126:TAOCK1>2.0.ZU;2-H
Abstract
Flavopiridol analogues, thio- and oxoflavopiridols which contain a sulfur ( 16) or oxygen (18) atom linker between a chromone ring and the hydrophobic side chain, are selective cyclin-dependent kinase 1 (CDK1) inhibitors with an IC50 Of 110 and 130 nM. These analogues were prepared from key intermedi ate 7 by substituting the ethyl sulfoxide. Enantio pure intermediate piperi done 10 was obtained from the racemic piperidone 8 via a very efficient "dy namic kinetic resolution" in 76% yield. Hydrophobic side chains such as chl orophenyl or tert-butyl produced potent CDK1 inhibitory activity, while hyd rophilic side chains such as pyrimidine or aniline caused a severe reductio n in CDK inhibitory activity. These analogues are competitive inhibitors wi th respect to ATP, and therefore activity was dependent upon the CDK subuni t without being affected by the cyclin subunit or protein substrate. Thio- and oxoflavopiridols 16 and 18 are not only selective within the CDK family but also discriminated between unrelated serine/threonine and tyrosine pro tein kinases. CDK1 selective thio- and oxoflavopiridol analogues inhibit th e colony-forming ability of multiple human tumor cell lines and possess a u nique antiproliferative profile in comparison to flavopiridol.